Kim JS - Search Results

1

Enhancement of DC vaccine potency by activating the PI3K/AKT pathway with a small interfering RNA targeting PTEN.

Kim JH, Kang TH, Noh KH, Kim SH, Lee YH, Kim KW, Bae HC, Ahn YH, Choi EY, Kim JS, Lee KM, Kim TW. Kim JH, et al. Among authors: kim tw, kim sh, kim js, kim kw. Immunol Lett. 2010 Nov 30;134(1):47-54. doi: 10.1016/j.imlet.2010.08.008. Epub 2010 Aug 19. Immunol Lett. 2010. PMID: 20727912

2

Radiosensitization of tumor cells by modulation of ATM kinase.

Choi EK, Ji IM, Lee SR, Kook YH, Griffin RJ, Lim BU, Kim JS, Lee DS, Song CW, Park HJ. Choi EK, et al. Among authors: kim js. Int J Radiat Biol. 2006 Apr;82(4):277-83. doi: 10.1080/09553000600702346. Int J Radiat Biol. 2006. PMID: 16690595

3

Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells.

Choi EK, Terai K, Ji IM, Kook YH, Park KH, Oh ET, Griffin RJ, Lim BU, Kim JS, Lee DS, Boothman DA, Loren M, Song CW, Park HJ. Choi EK, et al. Among authors: kim js. Neoplasia. 2007 Aug;9(8):634-42. doi: 10.1593/neo.07397. Neoplasia. 2007. PMID: 17786182 Free PMC article.

4

Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA.

Han SE, Kang H, Shim GY, Suh MS, Kim SJ, Kim JS, Oh YK. Han SE, et al. Among authors: kim sj, kim js. Int J Pharm. 2008 Apr 2;353(1-2):260-9. doi: 10.1016/j.ijpharm.2007.11.026. Epub 2007 Nov 22. Int J Pharm. 2008. PMID: 18178348

5

Enhancement of radiotherapeutic effectiveness by temperature-sensitive liposomal 1-methylxanthine.

Jeong SY, Yi SL, Lim SK, Park SJ, Jung J, Woo HN, Song SY, Kim JS, Lee JS, Lee JS, Park HJ, Choi EK. Jeong SY, et al. Among authors: kim js. Int J Pharm. 2009 May 8;372(1-2):132-9. doi: 10.1016/j.ijpharm.2008.12.040. Epub 2009 Jan 10. Int J Pharm. 2009. PMID: 19167476

6

Pegylated poly-l-arginine derivatives of chitosan for effective delivery of siRNA.

Noh SM, Park MO, Shim G, Han SE, Lee HY, Huh JH, Kim MS, Choi JJ, Kim K, Kwon IC, Kim JS, Baek KH, Oh YK. Noh SM, et al. Among authors: kim ms, kim js, kim k. J Control Release. 2010 Jul 14;145(2):159-64. doi: 10.1016/j.jconrel.2010.04.005. Epub 2010 Apr 10. J Control Release. 2010. PMID: 20385182

7

Biodistribution and improved anticancer effect of NIK-siRNA in combination with 5-FU for hepatocellular carcinoma.

Kang SS, Cho HA, Kim JS. Kang SS, et al. Among authors: kim js. Arch Pharm Res. 2011 Jan;34(1):79-86. doi: 10.1007/s12272-011-0109-0. Epub 2011 Apr 6. Arch Pharm Res. 2011. PMID: 21468918

8

Suppression of hepatitis B virus-derived human hepatocellular carcinoma by NF-kappaB-inducing kinase-specific siRNA using liver-targeting liposomes.

Cho HA, Park IS, Kim TW, Oh YK, Yang KS, Kim JS. Cho HA, et al. Among authors: kim tw, kim js. Arch Pharm Res. 2009 Jul;32(7):1077-86. doi: 10.1007/s12272-009-1714-z. Epub 2009 Jul 31. Arch Pharm Res. 2009. PMID: 19641890

9

In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer.

Kim CE, Lim SK, Kim JS. Kim CE, et al. Among authors: kim js. J Control Release. 2012 Jan 30;157(2):190-5. doi: 10.1016/j.jconrel.2011.09.066. Epub 2011 Sep 16. J Control Release. 2012. PMID: 21963773

10

Loss-of-function screens of druggable targetome against cancer stem-like cells.

Song M, Lee H, Nam MH, Jeong E, Kim S, Hong Y, Kim N, Yim HY, Yoo YJ, Kim JS, Kim JS, Cho YY, Mills GB, Kim WY, Yoon S. Song M, et al. Among authors: kim wy, kim s, kim n, kim js. FASEB J. 2017 Feb;31(2):625-635. doi: 10.1096/fj.201600953. Epub 2016 Oct 20. FASEB J. 2017. PMID: 27811063 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,826 results

Search Page

Filters